233 related articles for article (PubMed ID: 20877351)
1. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.
Kesselring R; Thiel A; Pries R; Trenkle T; Wollenberg B
Br J Cancer; 2010 Oct; 103(8):1245-54. PubMed ID: 20877351
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in head and neck cancer.
Pries R; Wollenberg B
Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
[TBL] [Abstract][Full Text] [Related]
4. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
5. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.
De Costa AM; Schuyler CA; Walker DD; Young MR
Cancer Immunol Immunother; 2012 Jun; 61(6):927-39. PubMed ID: 22116344
[TBL] [Abstract][Full Text] [Related]
8. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
Young MR; Levingston CA; Johnson SD
Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironments direct the recruitment and expansion of human Th17 cells.
Su X; Ye J; Hsueh EC; Zhang Y; Hoft DF; Peng G
J Immunol; 2010 Feb; 184(3):1630-41. PubMed ID: 20026736
[TBL] [Abstract][Full Text] [Related]
10. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients.
Kesselring R; Thiel A; Pries R; Wollenberg B
Cell Immunol; 2011; 269(2):74-7. PubMed ID: 21570678
[TBL] [Abstract][Full Text] [Related]
11. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF
Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217
[TBL] [Abstract][Full Text] [Related]
13. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
Uppaluri R; Dunn GP; Lewis JS
Cancer Immun; 2008 Dec; 8():16. PubMed ID: 19053167
[TBL] [Abstract][Full Text] [Related]
14. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
15. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
[TBL] [Abstract][Full Text] [Related]
17. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
19. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma.
Chi LJ; Lu HT; Li GL; Wang XM; Su Y; Xu WH; Shen BZ
Clin Exp Immunol; 2010 Sep; 161(3):480-9. PubMed ID: 20646003
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]